CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR ‐34a

Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion

(2021) Xun Wu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Circular RNA MYLK promotes tumour growth and metastasis via modulating miR‐513a‐5p/VEGFC signalling in renal cell carcinoma

(2020) Jianfa Li et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Deregulation of Circular RNAs in Cancer From the Perspectives of Aberrant Biogenesis, Transport and Removal

(2019) Qiongqiong Wu et al.   Frontiers in Genetics

Circular RNA MYLK serves as an oncogene to promote cancer progression via microRNA-195/cyclin D1 axis in laryngeal squamous cell carcinoma

(2019) Xiaohui Duan et al.   BIOSCIENCE REPORTS

Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p

(2019) Zhiqin Li et al.   Cancer Cell International

MiR‐34a inhibits the proliferation, migration, and invasion of oral squamous cell carcinoma by directly targeting SATB2

(2019) Xin Ge et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Effects of hsa_circRBM23 on Hepatocellular Carcinoma Cell Viability and Migration as Produced by Regulating miR-138 Expression

(2018) Baoyong Wang et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

CircRNA-Cdr1as Exerts Anti-Oncogenic Functions in Bladder Cancer by Sponging MicroRNA-135a

(2018) Peng Li et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis

(2018) Xiaobing Liu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer

(2018) Xiaojie Yu et al.   Cell Death & Disease

Circular RNA Myosin Light Chain Kinase (MYLK) Promotes Prostate Cancer Progression through Modulating Mir-29a Expression

(2018) Yuanqing Dai et al.   MEDICAL SCIENCE MONITOR

Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway

(2018) Zhihua Zeng et al.   JOURNAL OF CELLULAR PHYSIOLOGY

FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence

(2016) Ana Blanca et al.   Biomarkers in Medicine

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells

(2016) Peixin Dong et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer

(2016) Dmitriy Smolensky et al.   Drug Design Development and Therapy

Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence

(2015) Angeline S. Andrew et al.   INTERNATIONAL JOURNAL OF CANCER

Clinical and pathological implications of miRNA in bladder cancer

(2015) Cornelia Braicu et al.   International Journal of Nanomedicine

Immunological basis in the pathogenesis and treatment of bladder cancer

(2014) David B Thompson et al.   Expert Review of Clinical Immunology

MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44

(2014) Gan Yu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Circular RNAs are a large class of animal RNAs with regulatory potency

(2013) Sebastian Memczak et al.   NATURE

Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy

(2011) L Galluzzi et al.   ONCOGENE

Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAs

(2009) Shuo Gu et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY